CTS Awards

Tisha S. Wang MD, ATSF

Professor of Clinical Medicine, Senior Executive Clinical Vice Chair of the UCLA Department of Medicine; Clinical Director of PAP Foundation.

Dr. Tisha Wang received her MD from the University of Texas Medical Branch at Galveston, graduating with highest honors. She completed her internal medicine residency and pulmonary/critical care fellowship at UCLA before joining the faculty at UCLA in 2008. Dr. Wang is currently a Professor of Clinical Medicine in the David Geffen School of Medicine (DGSOM) at UCLA, where she serves as the Senior Executive Clinical Vice Chair for the Department of Medicine (DOM). She is board-certified in pulmonary, critical care, and sleep medicine. In addition to providing clinical care in the ICU and clinic, Dr. Wang was the UCLA pulmonary/critical care fellowship program director for 10 years until 2021 and also served as Clinical Chief of the UCLA Division of Pulmonary, Critical Care, Sleep Medicine, Allergy and Immunology until 2023. She was the co-director of the pandemic response team at UCLA and subsequently catalyzed the formation of the UCLA DOM Wellness Committee in 2021 to focus on physician well-being after noticing the effects of the pandemic on an already burned-out workforce.

In her academic career, Dr. Wang has had the privilege of educating and mentoring hundreds of residents, fellows, staff, and junior/mid-level faculty. She has been nominated for multiple teaching awards both locally and nationally and was awarded the UCLA Serge & Yvette Dadone Clinical Teaching Award in 2019. In 2020, she was honored as the recipient of the UCLA Sherman Melinkoff Award, which recognizes the “finest in doctor-patient relationships and medical education” and is considered the highest honor of the UCLA DGSOM. Recently Dr. Wang was chosen as the 2022 California Thoracic Society “Woman of the Year” and in April of this year, she graduated from the prestigious Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) program.

In addition to her clinical work and leadership responsibilities, Dr. Wang conducts research on rare lung disease with a focus on pulmonary alveolar proteinosis (PAP). She is the Clinical Director and Vice President of the patient-based PAP Foundation. Dr. Wang has served as Chair of the Education Committee for the American Thoracic Society since 2020 with a seat on the ATS Board of Directors and is the current President of the California Thoracic Society. In addition to championing the well-being of physicians, her greatest joys in medicine have been focused on advocacy for women in medicine, medical educators, and patients with rare lung disease.

Susan Murin, M.D., M.Sc., M.B.A., is the Interim Dean of the UC Davis School of Medicine and leads the nationally ranked medical school in its education, research, clinical care, and community partnership missions. Dr. Murin most recently served as Vice Dean for Clinical Affairs and Executive Director of the UC Davis Medical Group. She previously served as Chief of the Division of Pulmonary, Critical Care and Sleep Medicine, Vice Chair for Clinical Affairs and Executive Vice Chair of Internal Medicine, and Chief of the Medical Staff at UC Davis.

Her past national service has included membership on the Accreditation Council for Graduate Medical Education Internal Medicine RRC, Chair of the Pulmonary Medicine test-writing committee for the American Board of Internal Medicine (ABIM), member of the ABIM Pulmonary Board, and Chair of the Association of Pulmonary and Critical Care Medicine Program Directors. She has a long history of service to professional societies in various roles and recently served as Deputy Editor of CHEST, a leading respiratory journal.

Dr. Murin received her undergraduate degree from Rutgers University and completed her medical degree at New York University School of Medicine. She did her residency in Internal Medicine at NYU-Bellevue and fellowship in Pulmonary and Critical Care Medicine at Yale University/Yale-New Haven Hospital. She subsequently received an M.Sc. in Clinical Epidemiology (with a concentration in Clinical Effectiveness) from the Harvard T.H. Chan School of Public Health and an M.B.A. from the UC Davis Graduate School of Management.

Immediately after her clinical training, Dr. Murin served as an officer in the U.S. Air Force Medical Corps and has subsequently had a long tenure at UC Davis while also serving veterans through a joint appointment at the Mather Veterans Administration facility. She has been repeatedly named to Best Doctors lists regionally and nationally, practicing and teaching at UC Davis and the Sacramento VA Hospital.

Dr. Murin's research has focused on the effects of smoking on the natural history of breast cancer and the epidemiology of venous thromboembolism

Dr. Tisha Wang received her MD from the University of Texas Medical Branch at Galveston, graduating with highest honors. She completed her internal medicine residency and pulmonary/critical care fellowship at UCLA before joining the faculty at UCLA in 2008. Dr. Wang is currently a Professor of Clinical Medicine in the David Geffen School of Medicine (DGSOM) at UCLA, where she serves as the Senior Executive Clinical Vice Chair for the Department of Medicine (DOM). She is board-certified in pulmonary, critical care, and sleep medicine. In addition to providing clinical care in the ICU and clinic, Dr. Wang was the UCLA pulmonary/critical care fellowship program director for 10 years until 2021 and also served as Clinical Chief of the UCLA Division of Pulmonary, Critical Care, Sleep Medicine, Allergy and Immunology until 2023. She was the co-director of the pandemic response team at UCLA and subsequently catalyzed the formation of the UCLA DOM Wellness Committee in 2021 to focus on physician well-being after noticing the effects of the pandemic on an already burned-out workforce.

In her academic career, Dr. Wang has had the privilege of educating and mentoring hundreds of residents, fellows, staff, and junior/mid-level faculty. She has been nominated for multiple teaching awards both locally and nationally and was awarded the UCLA Serge & Yvette Dadone Clinical Teaching Award in 2019. In 2020, she was honored as the recipient of the UCLA Sherman Melinkoff Award, which recognizes the “finest in doctor-patient relationships and medical education” and is considered the highest honor of the UCLA DGSOM. Recently Dr. Wang was chosen as the 2022 California Thoracic Society “Woman of the Year” and in April of this year, she graduated from the prestigious Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) program.

In addition to her clinical work and leadership responsibilities, Dr. Wang conducts research on rare lung disease with a focus on pulmonary alveolar proteinosis (PAP). She is the Clinical Director and Vice President of the patient-based PAP Foundation. Dr. Wang has served as Chair of the Education Committee for the American Thoracic Society since 2020 with a seat on the ATS Board of Directors and is the current President of the California Thoracic Society. In addition to championing the well-being of physicians, her greatest joys in medicine have been focused on advocacy for women in medicine, medical educators, and patients with rare lung disease.

Dr. Shazia Jamil is a member of the Scripps Clinic Division of Chest and Critical Care Medicine, in La Jolla, California, and assistant professor of medicine at University of California, San Diego School of Medicine. She specializes in internal medicine, pulmonary medicine, critical care medicine and sleep medicine. She is actively involved in teaching, clinical practice and research in the arena of lung, sleep and critical care diseases. She has co-authored several journal articles and has contributed many book chapters in medical textbooks.

Dr. Jamil obtained her medical degree from the prestigious Aga Khan Medical University in Pakistan, followed by internship and residency training in internal medicine at University of Southern California. She was trained as a physician-scientist at the University of California, San Diego where she did her clinical fellowship training in pulmonary/critical care medicine, post-doctoral fellowship in molecular/cell biology and sleep medicine training. During her fellowship, she was selected to attend Harvard School of Public Health to further her education and training in areas of statistics, epidemiology and clinical trials.

Dr. Steven Hays, a pulmonologist, is medical director of the UCSF Lung Transplant Program, which is known for accepting patients with complex conditions while maintaining superior survival rates. His expertise is in caring for patients with end-stage lung disease who proceed through the lung transplant process. He treats conditions that include cystic fibrosis, emphysema associated with alpha-1 antitrypsin deficiency, and interstitial lung disease.

In research, Hays focuses on studying how airway remodeling occurs in the transplanted lung.

Hays earned his medical degree at the University of Kansas. He completed a residency in internal medicine at the University of Kansas Medical Center, where he served as chief resident, followed by a fellowship in pulmonary and critical care medicine at UCSF. He also completed a lung transplant fellowship at Stanford Health Care.